Direct Targeting of Macrophages With Methylglyoxal-Bis-Guanylhydrazone Decreases SIV-Associated Cardiovascular Inflammation and Pathology

Journal of Acquired Immune Deficiency Syndromes - United States
doi 10.1097/qai.0000000000001297
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Inhibition of HIV Expression and Integration in Macrophages by Methylglyoxal-Bis-Guanylhydrazone

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2015English

Phase II Trial of Methylglyoxal Bis-Guanylhydrazone (MGBG) in Refractory Small Cell Lung Cancer

Investigational New Drugs
OncologyPharmacology
1990English

Therapeutic Targeting of Tumor Associated Macrophages.

English

Prevention of Cardiovascular Event Targeted Vascular Inflammation, and Pathology of Thrombosis

Japanese Journal of Thrombosis and Hemostasis
2019English

663. Targeting Tumor-Associated Macrophages for Cancer Therapy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Therapeutic Targeting of Tumor-Associated Macrophages in Pancreatic Neuroendocrine Tumors

International Journal of Cancer
Cancer ResearchOncology
2018English

Cardiovascular Pathology

Modern Pathology
Forensic MedicinePathology
2014English

Targeting of M2-Like Tumor-Associated Macrophages With a Melittin-Based Pro-Apoptotic Peptide

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Macrophages and Cardiovascular Health

Physiological Reviews
MedicinePhysiologyMolecular Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy